Disparities In Use Of HIV-Prevention Drug

The HIV-prevention drug, PrEP, can reduce the risk of contracting the virus that causes AIDS by 90 percent. Its use has expanded sharply in recent years — but primarily among a white demographic.

Disparities in use of the pill are also geographic. Nearly half of all PrEP users reside in five states that account for 37 percent of the U.S. population — California, Florida, New York, Illinois and Texas — according to AIDSVu. The majority of new HIV diagnoses — 52 percent — are in the South.

For more, read Anna Gorman’s coverage.

KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the core operating programs at KFF—an independent source of health policy research, polling, and journalism. Learn more about KFF.

<h1>Disparities In Use Of HIV-Prevention Drug</h1>
<div>		<time class="posted-on" datetime="2018-03-23T02:00:43-07:00">
			March 23, 2018		</time>
		</div>
<p>The HIV-prevention drug, PrEP, can reduce the risk of contracting the virus that causes AIDS by 90 percent. Its use has expanded sharply in recent years — but primarily among a white demographic.</p><p>Disparities in use of the pill are also geographic. Nearly half of all PrEP users reside in five states that account for 37 percent of the U.S. population — California, Florida, New York, Illinois and Texas — according to AIDSVu. The majority of new HIV diagnoses — 52 percent — are in the South.</p><p>For more, read <a href="https://californiahealthline.org/news/use-of-hiv-prevention-drug-grows-but-lags-among-non-whites/">Anna Gorman’s coverage</a>.</p><ul><li><a href="https://californiahealthline.org/multimedia/disparities-in-use-of-hiv-prevention-drug/?share=facebook">				Click to share on Facebook (Opens in new window)				Facebook			</a></li><li><a href="https://californiahealthline.org/multimedia/disparities-in-use-of-hiv-prevention-drug/?share=linkedin">				Click to share on LinkedIn (Opens in new window)				LinkedIn			</a></li><li><a href="https://californiahealthline.org/multimedia/disparities-in-use-of-hiv-prevention-drug/?share=x">				Click to share on X (Opens in new window)				X			</a></li><li><a href="mailto:?subject=%5BShared%20Post%5D%20Disparities%20In%20Use%20Of%20HIV-Prevention%20Drug&body=https%3A%2F%2Fcaliforniahealthline.org%2FMjcyMzA5&share=email">				Click to email a link to a friend (Opens in new window)				Email			</a></li><li><a href="https://californiahealthline.org/multimedia/disparities-in-use-of-hiv-prevention-drug/#print?share=print">				Click to print (Opens in new window)				Print			</a></li></ul><em><a href="https://kffhealthnews.org/about-us">KFF Health News</a> is a national newsroom that produces in-depth journalism about health issues and is one of the core operating programs at KFF—an independent source of health policy research, polling, and journalism. Learn more about <a href="https://www.kff.org/about-us">KFF</a>.</em><p><a href="https://californiahealthline.org/morning-briefing/">Subscribe</a> to KFF Health News' free Morning Briefing.</p>

Some elements may be removed from this article due to republishing restrictions. If you have questions about available photos or other content, please contact NewsWeb@kff.org.